ARCHIVES

Genentech Reps Not Welcome: Hospitals Urge Drug Maker to Reverse Policy On Supplying Avastin, Rituxan, & Herceptin

This article is from The Cancer Letter archive.

Vol. 40 No. 39 | October 17, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Community Outreach Planning Grants Still Open; Study Section Meetings May Be Opened By Courts

October 18, 1974

In Brief: Benjamin Neel named director of NYU Cancer Center

October 24, 2014

DOD Seeks to Fund Innovative Research In 438 Million Prostate Cancer Program

August 22, 1997

Memorial Sloan Kettering Seizes Top Cancer Hospital Prize From MD Anderson in U.S. News & World Report Ranking

July 15, 2014

Also Coltman to step down as SWOG chairman, Baker is chairman-elect.

July 25, 2003

Clinical Cooperative Groups Asked To Develop Tamoxifen Prevention Trial; CGOPs To Participate

July 6, 1990